February 6, 2019
Kyowa Hakko Kirin has grabbed the rights to commercialize Hisamitsu Pharmaceutical’s transdermal patch containing ropinirole, otherwise known as HP-3000, for the treatment of Parkinson’s disease in Japan. The two companies said on February 5 that they have signed an agreement...read more